组蛋白修饰在心血管疾病中的作用及研究进展(综述)
Role and research progress of histone modification in cardiovascular diseases (Review).
作者信息
Qi Qing, Li Lin, Liang Hao, Zeng Yidi
机构信息
School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, P.R. China.
Institute of TCM Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan 410208, P.R. China.
出版信息
Exp Ther Med. 2025 May 13;30(1):132. doi: 10.3892/etm.2025.12882. eCollection 2025 Jul.
As society evolves and lifestyles change, there has been a notable rise in the incidence of cardiovascular diseases due to a parallel rise in associated risk factors. In recent years, considerable research has been conducted on the impact of histone modifications in relation to these conditions. Processes such as acetylation, methylation and phosphorylation of histones, mediated by specific enzymes, are essential in the regulation of gene expression, which in turn influences cellular functions and the progression of diseases. Research shows that alterations in specific histone modifications are closely linked to the onset and advancement of cardiovascular conditions. For instance, significant variations in histone deacetylases and H3K27 methylation have been observed in cases of heart failure and myocardial ischemia-reperfusion injury. In the present review, it was aimed to summarize recent findings in this area, providing a foundation for further exploration of the mechanisms by which histone modifications contribute to cardiovascular diseases.
随着社会的发展和生活方式的改变,由于相关风险因素的同步增加,心血管疾病的发病率显著上升。近年来,针对组蛋白修饰与这些疾病的关系进行了大量研究。由特定酶介导的组蛋白乙酰化、甲基化和磷酸化等过程,在基因表达调控中至关重要,而基因表达调控反过来又会影响细胞功能和疾病进展。研究表明,特定组蛋白修饰的改变与心血管疾病的发生和发展密切相关。例如,在心力衰竭和心肌缺血-再灌注损伤病例中,已观察到组蛋白去乙酰化酶和H3K27甲基化存在显著差异。在本综述中,旨在总结该领域的最新研究结果,为进一步探索组蛋白修饰导致心血管疾病的机制奠定基础。